...
首页> 外文期刊>Journal of cardiac failure >Cardiomyopathy in a Dish: Using Human Inducible Pluripotent Stem Cells to Model Inherited Cardiomyopathies
【24h】

Cardiomyopathy in a Dish: Using Human Inducible Pluripotent Stem Cells to Model Inherited Cardiomyopathies

机译:在盘中的心肌病:使用人诱导的多能干细胞来模拟遗传性心肌病

获取原文
获取原文并翻译 | 示例
           

摘要

Inherited cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathies, arrythmogenic right ventricular cardiomyopathy, and other inherited forms of heart failure, represent a unique set of genetically defined cardiovascular disease processes. Unraveling the molecular mechanisms of these deadly forms of human heart disease has been challenging, but recent groundbreaking scientific advances in stem cell technology have allowed for the generation of patient-specific human inducible stem cell (hiPSC)-derived cardiomyocytes (CMs). hiPSC-derived CMs retain the genetic blueprint of the patient, they can be maintained in culture, and they recapitulate the phenotypic characteristics of the disease in vitro, thus serving as a disease in a dish. This review provides an overview of in vitro modeling of inherited cardiomyopathies with the use of patient-specific hiPSC-derived CMs.
机译:遗传性心肌病,包括肥厚性心肌病,扩张的心肌病,酸致肿瘤性右心室心肌病和其他遗传性形式的心力衰竭,代表了一组独特的遗传定义心血管疾病过程。 解开这些致命形式的人类心脏病的分子机制已经具有挑战性,但最近干细胞技术的突破性科学进步已经允许产生患者特异性人类诱导干细胞(HIPSC)的心肌细胞(CMS)。 HIPSC衍生的CMS保留了患者的遗传蓝图,它们可以保持在培养中,它们在体外重新制备疾病的表型特征,从而用作盘中的疾病。 本综述概述了使用患者特异性HIPSC衍生CMS的遗传性心肌病的体外建模概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号